Aurelio Fuertes Martín

Dose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics.

J. Gónzalez-Buitrago, M. Isidoro-García, C. Tovar, 2014, Pharmacogenomics.

[Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect].

Aurelio Fuertes Martín, H. T. L. Vega, Sandra Inés Revuelta, 2015 .

Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients.

Á. Carracedo, R. Cruz, A. Hurlé, 2014, Personalized medicine.

Hyperhidrosis in Association with Efavirenz

A. Hurlé, S. C. Figueroa, Aurelio Fuertes Martín, 2009 .